Skip to main content
. 2022 Sep 5;8(10):2084–2095. doi: 10.1021/acsinfecdis.2c00186

Figure 3.

Figure 3

(A) Graphic illustration depicting the ability of ADA or ferrocene to block the cavity of CB[7] and eliminate the antiviral effect. (B) Data from the TCID50 assays, illustrating the drop in titer when HSV-2 is exposed to CB[7] (n = 3) or ADA alone (n = 2), but no decrease in titer is observed when HSV-2 is mixed with CB[7] + ADA (n = 2). (C) Data from the TCID50 assays indicates that CB[7] + ferrocene (n = 1) and ferrocene alone (n = 3) have no antiviral effect.